Wilmington, MA, United States of America

Anne R Diers

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Anne R Diers

Introduction

Anne R Diers is an accomplished inventor based in Wilmington, MA (US). She has made significant contributions to the field of cancer treatment, particularly in addressing challenges associated with temozolomide-resistant glioma. Her innovative approaches have the potential to improve patient outcomes and advance medical science.

Latest Patents

Anne R Diers holds a patent for "Methods of treatment of temozolomide-resistant glioma using coenzyme Q10." This invention provides methods and compositions for treating a subject with a glioma that has failed treatment with temozolomide (TMZ). The treatment involves the administration of a composition comprising a Coenzyme Q10 compound to the subject. Additionally, the invention outlines a method for treating cancer that exhibits increased Complex II activity in a subject through the same administration.

Career Highlights

Throughout her career, Anne has demonstrated a commitment to advancing cancer treatment methodologies. Her work has garnered attention for its innovative approach to overcoming resistance in glioma treatments. With a focus on practical applications, she continues to contribute to the medical field through her research and inventions.

Collaborations

Anne R Diers collaborates with notable professionals in her field, including Niven Rajin Narain and Rangaprasad Sarangarajan. These partnerships enhance her research efforts and contribute to the development of effective treatment strategies.

Conclusion

Anne R Diers exemplifies the spirit of innovation in cancer treatment through her groundbreaking work on temozolomide-resistant glioma. Her contributions are paving the way for new therapeutic options and improving the lives of patients facing challenging diagnoses.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…